MetaStat
Montclair
About MetaStat
MetaStat is focused on developing and commercializing novel diagnostic technologies and therapeutics for the early and reliable prediction and treatment of systemic metastasis, a cancer that spreads from a primary tumor through the bloodstream to other areas of the body. The company also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $24.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2017)
- Ticker: otcqb:MTST
- Website: metastat.com
- Phone: (212) 796-8170
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/metastat-2297106 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.